Prof Mimi Tang

Prof Mimi TangMBBS PhD FRACP FRCPA FAAAAI

Allergy / Clinical Immunology - Paediatric VIC

Professor Tang is a Paediatric immunologist allergist at Melbourne’s Royal Children’s Hospital, Group Leader of Allergy Immunology Research and Director of the Food Allergy Translation Centre at the Murdoch Children’s Research Institute, and a Professor in the Department of Paediatrics at the University of Melbourne.She is also Chief Medical Officer at Prota Therapeutis and a Consultant immunopathologist at Dorevithch Pathology.

Professor Tang completed her medical degree at the University of Melbourne in 1986 followed by a PhD in Immunology in 1995. She is internationally recognized in the field of allergy and immunology and has authored more than 350 peer reviewed journal articles and book chapters. Her research programme is focused on developing a novel combination therapy for food allergies that harnesses the potent immune modulating capacity of intestinal microbiota alongside allergen oral immunotherapy to induce disease remission. If successful this exciting treatment approach will transform the way food allergies are managed, leaving behind allergen avoidance and allowing patients to eat their allergen freely. Recently, she has developed a highly effective novel treatment for food allergy that induced remission of peanut allergy in 80% of those treated. The patented probiotic food immunotherapy technology has been licensed to Prota Therapeutics, an Australian biotech start up company spun out of the Murdoch Children’s Research Institute.

Professor Tang has received national and international awards recognising her achievements in allergy immunology research and clinical care and is regularly invited to speak at major international scientific meetings in the field. She has recently completed a four-year term as Board Director of the World Allergy Organisation and currently sits on various expert committees of the American Academy of Allergy Asthma and Immunology, World Allergy Organisation and the Australasian Society of Clinical Immunology and Allergy.

Acute Anaphylaxis CSS
Acute Anaphylaxis Clinical Care Standard - Learn more...
Atopic Dermatitis
allergy250K teens/young adults
Food allergy training

Our Supporters

Diamond


Viatris
Sanofi
Nestle
Allergy Concepts

Platinum


  • Bulla
  • NSW Food Authority
  • Novartis
  • Pfizer

Gold


  • dbv technologies
  • Mondelez
  • Nurticia
Silver

  • abbvie
  • Australian Camps Association
  • Bayer
  • Sanctuary Early Learning
  • Sweet William

© 2022 ALLERGY & ANAPHYLAXIS AUSTRALIA
ABN: 70 693 242 620

 


ALLERGY & ANAPHYLAXIS AUSTRALIA
is supported by funding from the
Australian Government,
Department of Health.


ALLERGY & ANAPHYLAXIS AUSTRALIA acknowledges and pays respect to the traditional custodians of the lands on which we work, live and play.

IN AN EMERGENCY

If you are having an allergic reaction follow advice on your ASCIA Action Plan.

If in doubt, give the Anapen® or EpiPen®.

Do not call us for emergency advice.

If you do not have an ASCIA Action Plan and/or an Anapen® or EpiPen® call triple zero (000) for an ambulance.